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Abstract 
In the present work, methanolic, ethanolic and boiled water extracts of Suillus collinitus 
were chemically characterized and further submitted to evaluation of their bioactive 
properties (antioxidant potential and cytotoxic activity in tumor cell lines). Phenolic 
acids and sugars were chromatographically identified and quantified in the methanolic 
and boiled water extracts, respectively. S. collinitus ethanolic extract gave the highest 
antioxidant activity. Nevertheless, regarding cell growth inhibition, the methanolic 
extract was the most potent one, particularly in MCF-7 cells (GI50 25.2±0.2µg/ml). 
Moreover, the GI50 concentration induced a G1 cell cycle arrest, with a concomitant 
decrease in the percentage of cells in the S phase. Furthermore, it caused an increase in 
the percentage of apoptotic cells, from 6.0±0.2% in untreated cells, to 15.3±2.0% in 
cells treated with the GI50 concentration and to 16.3±2.0% in cells treated with 2×GI50 
concentration. In addition, 48 h treatment with the GI50 concentration caused a strong 
increase in the levels of p53, p21, and cleaved PARP, together with a decrease in Bcl-2 
and XIAP. Results indicate that Suillus collinitus may be a promising source of 
bioactive compounds. Particularly, its methanolic extract appears to have a p53-
mediated effect on the normal cell cycle distribution and apoptosis induction in a human 
breast tumor cell line.  
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1. Introduction  
Cancer has become a major public health problem in Europe with an estimated 
prevalence of about 3%, increasing to 15% at old age. Moreover, cancer related deaths 
are projected to increase to over 11 million in 2030 (World Health Organization, 2010). 
Breast cancer is the major health problem in women worldwide, regarding both its 
incidence and mortality, which is emphasised by the diagnosis of over one million new 
cases annually (Botha, Bray, Sankila, & Parkin, 2003; Ferlay et al., 2007; Ferlay et al., 
2008; Stankov & Stankov, 2011). Indeed, breast cancer is the most frequently diagnosed 
cancer and the leading cause of cancer death among females, accounting for 23% of the 
total cancer cases and 14% of the cancer deaths (Jemal et al., 2011).  
Mushrooms are part of the sexual life cycle of particular fungi with specific metabolic 
pathways, and therefore may contain a largely unexploited source of powerful new 
pharmaceutical products with potential antitumor properties. Furthermore, they may 
have potential as functional foods (Borchers, Keen, & Gershwin, 2004; Ferreira, Vaz, 
Vasconcelos, & Martins, 2010; Moradali, Mostafavi, Ghods, & Hedjaroude, 2007; 
Zaidman, Yassin, Mahajana, & Wasser, 2005). The most important molecules found in 
mushrooms with antitumor potential include polysaccharides and phenolic compounds 
or derivatives (Ferreira et al., 2010; Liu et al., 2009; Vaz, Almeida, Ferreira, Martins, & 
Vasconcelos, 2012; Wasser, 2002; Zhang, Cui, Cheung, & Wang, 2007; Zhou & Chen, 
2011). Furthermore, the antioxidant activity of the latter has been extensively reported, 
namely as free radical inhibitors (chain breaker), peroxide decomposers, metal 
inactivators or oxygen scavengers (Ferreira, Barros, & Abreu, 2009; Palacios et al., 
2011). Suillin, a derivative of a phenolic acid (protocatechuic acid) belonging to the 
prenylphenols class isolated from the mushroom Suillus placidus, has proven to be a 
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potent apoptosis inducer in human hepatoma HepG2 cells (Liu et al., 2009). Like S. 
placidus, Suillus collinitus is also an edible mycorrhizal mushroom found in European 
pine forests, belonging to the same genus Suillus in the Suillaceae family. Nevertheless, 
to the best of our knowledge there is no report of antitumour potential for this 
mushroom species.  
In the present work, methanolic, ethanolic and boiled water extracts of S. collinitus were 
submitted to bioactivity evaluation through in vitro antioxidant potential (mainly free 
radical scavenging activity and reducing power) and cytotoxic activity in various tumor 
cell lines: lung, breast, colon and gastric cancer. The extracts were chemically 
characterized in their phenolic acids and sugars composition by chromatographic 
techniques. The extract with highest cells growth inhibitory activity (methanolic extract) 
was chosen to be further investigated regarding its possible mechanism of action in the 
most susceptible cell line studied (breast cancer), by cell cycle and apoptosis evaluation. 
Furthermore, being etoposide one of the major standard cytotoxic drugs used in 
polychemotherapy, its concomitant use with S. collinitus methanolic extract was also 
studied in the same cells. 
 
2. Materials and methods 
2.1. Standards and reagents 
Acetonitrile 99.9% was of HPLC grade from Lab-Scan (Lisbon, Portugal). All the other 
solvents and chemicals were of analytical grade purity. Ethanol was supplied by 
Pronalab (Lisbon, Portugal). Sugar standards (L(+)-arabinose, D(−)-fructose, D(+)-
mannitol and D(+)-trehalose) were purchased from Sigma (St. Louis, MO, USA). 2,2-
Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, MA, 
USA). Water was treated in a Milli-Q water purification system (TGI Pure Water 
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Systems, USA). Fetal bovine serum (FBS), L-glutamine, phosphate buffer saline (PBS), 
trypsin and RNase A were from Gibco Invitrogen Co. (Paisley, UK). RPMI-1640 
medium was from Lonza (Basel, Switzerland). Acetic acid, dimethylsulfoxide (DMSO), 
sulforhodamine B (SRB), trypan blue, propidium iodide (PI) and phenolic standards 
were from Sigma Chemical Co. (St. Louis, USA). Trichloroacetic acid (TCA) and Tris 
were sourced from Merck (Darmstadt, Germany). Primary and secondary antibodies 
were from Santa Cruz Biotechnology Inc. (Heidelberg, Germany).  
 
2.2. Samples and preparation of the extracts 
Samples of Suillus collinitus (Fr.) Kuntz (edible mushroom) were collected in Bragança 
(Northeast Portugal). Taxonomic identification of sporocarps was made according to 
Coutecuisse & Duhem (2005) and representative voucher specimens were deposited at 
the herbarium of Escola Superior Agrária of Instituto Politécnico de Bragança. The 
samples were lyophilised (Ly-8-FM-ULE, Snijders, Holland) and reduced to a fine 
powder (20 mesh). 
Methanolic, ethanolic and boiled water extracts were prepared from the lyophilised 
powder following the procedure previously described by us (Vaz et al., 2010). For the 
antioxidant activity assays, each extract was re-dissolved in the corresponding solvent, 
while for the tumour cell growth screening assays, the extracts were re-dissolved in 
DMSO (a stock solution was prepared and then further diluted until the determination of 
GI50 values). Final concentration of DMSO showed no interference with the biological 
activity tested. The solutions were stored at -20 ºC until further use. 
 
2.3. Chemical characterization of the extracts 
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Phenolic acids were analysed by high performance liquid chromatography coupled to a 
photodiode array detector (HPLC-DAD) according to a previous report of the authors 
(Vaz et al., 2011a).  
Sugars were determined, after crude polysaccharides hydrolysis, by high performance 
liquid chromatography coupled to a refraction index detector (HPLC-RI) as previously 
described by the authors (Heleno et al., 2012), using fructose as internal standard (IS). 
The equipment consisted of an integrated system with a pump (Knauer, Smartline 
system 1000), degasser system (Smartline manager 5000), auto-sampler (AS-2057 
Jasco) and a RI detector (Knauer Smartline 2300). The chromatographic separation was 
achieved with a Eurospher 100-5 NH2 column (4.6 × 250 mm, 5 µm, Knauer) operating 
at 30 ºC (7971 R Grace oven). The mobile phase was acetonitrile:deionized water, 
70:30 (v/v) at a flow rate of 1 ml/min. Sugars identification and quantification was 
made according to standards and data were analysed using Clarity 2.4 Software 
(DataApex). The results are expressed in g per kg of dry weight (dw).  
 
2.4. Screening of antioxidant activity 
DPPH radical-scavenging activity. This methodology was performed using an ELX800 
Microplate Reader (Bio-Tek Instruments, Inc), according to Vaz et al. (2011b). The 
reaction mixture in each one of the 96-wells consisted of one of the serial concentrations 
of the extracts (30 µl) and aqueous methanolic solution (80:20 v/v, 270 µl) containing 
DPPH radicals (6×10-5 mol.l-1). The mixture was left to stand for 60 min in the dark. 
The reduction of the DPPH radical was determined by measuring the absorption at 515 
nm. The radical scavenging activity (RSA) was calculated as a percentage of DPPH 
discolouration using the equation: % RSA = [(ADPPH-AS)/ADPPH] × 100, where AS is the 
absorbance of the solution when the sample extract has been added at a particular level, 
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and ADPPH is the absorbance of the DPPH solution. The extract concentration providing 
50% of radicals scavenging activity (EC50) was calculated from the graph of RSA 
percentage against extract concentration. Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid) was used as standard. 
 
Reducing power. The serial concentrations of the extracts (0.5 ml) were mixed with 
sodium phosphate buffer (200 mmol.l-1, pH 6.6, 0.5 ml) and potassium ferricyanide (1 
% w/v, 0.5 ml). The mixture was incubated at 50 ºC for 20 min, and trichloroacetic acid 
(10% w/v, 0.5 ml) was added. The mixture (0.8 ml) was poured in the 48-wells, as also 
deionised water (0.8 ml) and ferric chloride (0.1% w/v, 0.16 ml), and the absorbance 
was measured at 690 nm in the Microplate Reader described above (Vaz et al., 2011b). 
The extract concentration providing 0.5 of absorbance (EC50) was calculated from the 
graph of absorbance at 690 nm against extract concentration. Trolox was used as 
standard. 
 
Inhibition of β-carotene bleaching. The antioxidant activity of the extracts was 
evaluated by the β-carotene linoleate model system. A solution of β-carotene was 
prepared by dissolving β-carotene (2 mg) in chloroform (10 ml). Two millilitres of this 
solution were added to a 100 ml round-bottom flask. After the chloroform was removed 
at 40 ºC under vacuum, linoleic acid (40 mg), Tween® 80 emulsifier (400 mg), and 
distilled water (100 ml) were added to the flask and vigorously shaken. Aliquots (4.8 
ml) of this emulsion were transferred into different test tubes containing serial 
concentrations (0.2 ml) of the extracts. The tubes were shaken and incubated at 50 ºC in 
a water bath (Vaz et al., 2011b). As soon as the emulsion was added to each tube, the 
zero time absorbance at 470 nm was measured. Inhibition of β-carotene bleaching was 
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calculated using the following equation: Absorbance after 2 h of assay/Initial 
Absorbance) × 100. The extract concentration providing 50% antioxidant activity 
(EC50) was calculated by interpolation from the graph of antioxidant activity percentage 
against extract concentration. Trolox was used as standard.  
 
2.5. Screening of growth inhibition activity in human tumour cell lines  
The effects of the extracts on the growth of human tumour cell lines was evaluated 
according to the procedure adopted in the NCI’s in vitro anticancer drug screening, 
which uses sulforhodamine B (SRB) assay to assess cell growth inhibition (Skehan et 
al., 1990). Four human tumour cell lines were used: NCI-H460 (lung cancer), MCF-7 
(breast cancer), HCT-15 (colon cancer) and AGS (gastric cancer). Cells were routinely 
maintained as adherent cell cultures in RPMI-1640 medium containing 5% heat-
inactivated FBS at 37 ºC, in a humidified air incubator containing 5% CO2. Each cell 
line was plated at an appropriate density (5.0 × 103 cells/well for NCI-H460 and MCF-
7, 1.0 × 104 cells/well for HCT-15 and 7.5 × 103 cells/well for AGS) in 96-well plates 
and allowed to attach for 24 h. Cells were then treated for 48 h with various extract 
concentrations. The DMSO concentrations used (0.2 to 0.8%) have no growth inhibitory 
effect in these cell lines. 
Following this incubation period, the adherent cells were fixed with 10% trichloroacetic 
acid (final concentration), stained with SRB and excess dye washed with 1% acetic 
acid. The bound SRB was solubilised with 10 mM Tris and the absorbance was 
measured at 490 nm in a microplate reader (Multi-mode microplate synergy™ MX, 
Biotek) and analysed with the Gen5™ software (Biotek). The concentration that 
inhibited growth in 50% (GI50) was calculated as described by Monks et al. (1991). The 
growth inhibitory activity of the extracts was inferred from the SRB assay by comparing 
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the absorbance of the wells containing extract-treated cells with the absorbance of the 
wells containing untreated cells, 48 h following treatment with the extracts, and 
subsequently comparing these results with the ones obtained for cells that had been 
fixed at time zero (time at which extracts were added).  
 
2.6. Cell cycle distribution analysis and apoptosis detection  
For the analysis of cell cycle phase distribution, MCF-7 cells were plated at 1.5×105 
cells/ml in 6-well plates and left incubating for 24 hours. Cells were then incubated with 
complete medium (blank), or with S. collinitus methanolic extract at the GI50 and 2×GI50 
concentrations. The DMSO concentrations used have no effect on the cell cycle profile. 
Cells were harvested following a 48 h incubation period with the extract and further 
processed for either cell cycle analysis or apoptosis detection. For cell cycle analysis, 
cells were fixed in 70% ethanol and kept at 4 ºC until analysis. Prior to analysis, cells 
were incubated with PI (5 µg/ml) and RNase A in PBS (100 µg/ml) for 30 min on ice 
(Vaz et al., 2012). Apoptosis was assayed with the Human Annexin V-FITC/PI 
apoptosis Kit (Bender MedSystems, Vienna, Austria) according to the manufacturer’s 
instructions, as previously described by us (Queiroz et al., 2010). 
Cellular DNA content (for cell cycle distribution analysis and presence of sub-G1 peak, 
which is suggestive of apoptosis induction) and measurement of phosphatidylserine 
externalization (for apoptosis detection) were analyzed using an Epics XL-MCL Coulter 
flow cytometer plotting at least 20,000 events per sample. Cell cycle distribution and 
apoptosis data analysis were subsequently performed using the FlowJo 7.2 software 
(Queiroz et al., 2010).  
 
2.7. Protein expression analysis 
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For analysis of protein expression, MCF-7 cells were treated with complete medium 
(blank), or with S. collinitus methanolic extract at the GI50 and 2×GI50 concentration, 
and processed 48 h after incubation. DMSO controls were also tested. Cells were lysed 
in Winman’s buffer (1% NP-40, 0.1 M Tris-HCl pH 8.0, 0.15 M NaCl and 5 mM 
EDTA) with EDTA-free protease inhibitor cocktail (Boehringer, Mannheim, Germany). 
Proteins were quantified using the DC Protein Assay Kit (BioRad, Hercules, CA, USA) 
and separated in 12% tris-glycine sodium dodecyl sulfate (SDS)-polyacrylamide gel. 
Proteins were then transferred to a nitro-cellulose membrane (GE Healthcare, Madrid, 
Spain). The membranes were incubated with the following primary antibodies for poly 
(ADP-ribose) polymerase (PARP) (1:4000), p53 (1:200), XIAP (1:1000), Bcl2 (1:100), 
p21 (1:200) and Actin (1:2000), and further incubated with the appropriate secondary 
antibodies conjugated with horseradish peroxidase (HRP) diluted 1:2000 in 5% non-fat 
dried milk in T-TBS. The signal was detected with the Amersham ECL kit (GE 
Healthcare) using the Hyperfilm ECL (GE Healthcare) and the Kodak GBX developer 
and fixer twin pack (Sigma) (Vaz et al., 2012).      
 
2.8. Cell growth inhibition following treatment of cells concomitantly with etoposide 
and S. collinitus methanolic extract 
The effects of the concomitant use of etoposide and S. collinitus methanolic extract on 
the growth of MCF-7 cells was evaluated according to the procedure previously 
described in section 2.5. Etoposide was used at 1 µM (approximately the GI50 
concentration in this cell line, previously determined), and the extract was used at the 
previously determined GI50 concentration.   
 
2.9. Statistical analysis 
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For each assay 3 to 6 independent experiments were performed in triplicate (antioxidant 
activity assays) or duplicate (antitumour activity assays), and the results were expressed 
as mean values ± standard deviation (SD) or standard error (SEM). One-way analysis of 
variance (ANOVA) followed by Tukey’s HSD Test was performed with the SPSS 
v.16.0 software. Differences in p values bellow 0.05 were considered statistically 
significant. 
 
3. Results and discussion 
3.1. Chemical characterization and screening of bioactive properties 
The methanolic and boiled water (after hydrolysis of crude polysaccharides with 
trifluoroacetic acid) extracts were analyzed by HPLC-DAD and HPLC-RI, respectively 
and the results are given in Table 1. Two phenolic acids, p-hydroxybenzoic and 
protocatechuic acids, and one related compound, cinnamic acid, were found. Regarding 
sugars composition, mannitol, arabinose and trehalose were identified and quantified in 
S. collinitus (Figure 1). 
Three different assays were carried out for the in vitro evaluation of the antioxidant 
properties of the methanolic, ethanolic and boiled water extracts: scavenging activity on 
DPPH radicals, inhibition of lipid peroxidation in a β-carotene-linoleate system and 
reducing power. The methanolic extract revealed the lowest antioxidant activity (highest 
EC50 values; extract concentration that achieves 50% of antioxidant activity or 0.5 of 
reducing power) in all the assays (Table 2). The antioxidant properties of ethanolic and 
boiled water extracts were similar (without significant statistical differences), except for 
reducing power which was higher in the ethanolic extract (1.3 mg/ml, Table 2). The 
observed antioxidant potential might be related to the phenolic acids found (Table 1) 
and their reported chemoprotective effects against oxidative stress-mediated disorders 
 
 
 
12 
mainly from their free radical scavenging and metal chelating properties (Soobrattee, 
Neergheen, Luximon-Ramma, Aruoma, & Bahorun, 2005).  
The effects of the S. collinitus extracts on the growth of four human tumour cell lines 
(NCI-H460, MCF-7, HCT-15 and AGS), represented as the concentrations that caused 
50% of cell growth inhibition (GI50), are summarized in Table 3. The methanolic 
extract was the most potent in all tested cell lines, presenting GI50 values that ranged 
from 25.2 to 103.2 µg/ml for the MCF-7 and HCT-15 cells, respectively. Its activity 
could be related to the phenolic compounds found in the extract who have already 
demonstrated capacity to decrease viable cells number, mostly when they are 
concomitantly used (Vaz et al., 2012). 
The boiled water extract did not show any effect on the cell lines at the tested 
concentrations (up to 400 µg/ml), as it can be observed, for example, in the dose-
response effect of the three extracts on MCF-7 cell line  (Figure 2).  
MCF-7 cell line was the most susceptible (presenting the lowest GI50) to S. collinitus 
methanolic extracts. Therefore, this most active extract was chosen to be further 
investigated regarding its possible mechanism of action in this cell line. 
 
3.2. Effects on cell cycle profile and apoptosis induction  
The MCF-7 cell line was incubated with the GI50 (25.2 µg/ml) or twice the GI50 (50.4 
µg/ml) concentrations of the mushroom’s extract for 48 h and their effects on the 
normal cell cycle distribution and induction of apoptosis were studied.  
Analysis of the effect of the methanolic extract on cell cycle was performed by flow 
cytometry and results show that both the GI50 concentration and 2×GI50 concentration 
induced a G1 cell cycle arrest, with a concomitant decrease in the percentage of cells in 
the S phase (Figure 3). 
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Additionally, it was investigated whether S. collinitus induced apoptosis in the MCF-7 
cell line, using the annexin V-FICT/PI flow cytometry assay. MCF-7 cells treated with 
the methanolic extract for 48 h presented an increase in the percentage of apoptotic 
cells, from 6.0±0.2% in untreated cells, to 15.3±2.0% in cells treated with the GI50 
concentration and to 16.3±2.0 % in cells treated with 2×GI50 concentration (Table 4).  
Furthermore, the effect of the mushroom extract on the expression of some proteins 
involved in the apoptotic process was determined by Western blot. Results show that 
treatment of MCF-7 cells with the GI50 concentration of the extract caused a strong 
increase in the levels of p53. This effect was even stronger when cells were treated with 
2×GI50 concentration, suggesting that the effect is concentration-dependent. 
Accordingly, the levels of p21 whose expression is regulated by p53 and related to cell 
cycle arrest were also increased in a concentration dependent manner with the GI50 and 
with the 2× GI50 concentrations.  Finally, treatment of the cells with the extract caused a 
decrease in the levels of XIAP and Bcl-2 and a concentration dependent increase in the 
levels of cleaved PARP, which are consistent with an apoptotic process of cell death 
(Figure 4). 
Etoposide is one of the major standard cytotoxic drugs used for different cancers and 
frequently used in polychemotherapy. Therefore, the effect of treating MCF-7 cells 
concomitantly with S. collinitus (methanolic extract) and etoposide was also studied, by 
verifying the % of cell growth upon a 48 h incubation with the previously determined 
approximate GI50 concentration of etoposide (1 µM) and with the GI50 (25.2 µg/ml) of 
the extract. The combined use of the methanolic extract and etoposide caused a greater 
decrease in the % of cell growth, when compared to either of them used individually, 
indicating the potential benefit of this combination (Figure 5). 
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Overall, the S. collinitus ethanolic extract gave highest scavenging properties and 
reducing power, while the methanolic extract was the most potent inhibiting the growth 
of tumour cell lines (NCI-H460, MCF-7, HCT-15 and AGS).  
Natural antioxidants may have different means for exerting their action, including 
interactions with intracellular signal transduction pathways or inducing the expression 
of antioxidant and detoxification enzymes. In this context, it is becoming now more 
evident that the pro-oxidant effect, rather than the antioxidant, is the key event at the 
basis of antiproliferative effect exerted by natural antioxidants on the cells (Chen et al., 
2008; Ullah et al., 2011; Weisburg et al, 2010; Zhang et al., 2010). Nevertheless, within 
the present study it is not clear if antioxidant or pro-oxidant effects are related to 
antiproliferative activity. Based on the in vitro assays performed, only antioxidant 
effects were found: mainly scavenging activity and reducing power. Apparently, there is 
no correlation between both activities (in vitro antioxidant activity and antiproliferative 
activity using human cells), because ethanolic extract revealed the highest antioxidant 
potential, while methanolic extract gave the highest antiproliferative activity. 
MCF-7 cells were the most susceptible of the cells studied, and the methanolic extract 
appears to have a p53-mediated effect on the normal cell cycle distribution and 
apoptosis induction in these cells. Suillus collinitus is a promising source of bioactive 
compounds, however further studies will be necessary such as analysis of its effect in 
non-tumour cells and the isolation and identification of the compounds present in the 
methanolic extract which may be responsible for the obtained results. Nonetheless, it is 
possible that the activity here described may be caused by the combination of several 
compounds and not by any individually isolated compound.  
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Table 1. Phenolic acids, derivatives and sugars (after crude polysaccharides hydrolysis) 
in the Suillus collinitus extracts.  
 
 
 
 
 
 
 
 
Results are expressed in mg/kg (phenolic acids) or g/kg (sugars) in dry weight basis, 
and show means ± SD of 3 independent experiments performed in triplicate.*Vaz et al., 
2011.  
  
 
Methanolic extract* 
Protocatechuic acid 5.2 ± 0.2  
 p-Hydroxybenzoic acid 14.1 ± 1.2  
 Cinnamic acid 1.3 ± 0.2  
 Boiled water extract 
Arabinose 30.3 ± 5.5  
Mannitol 32.2 ± 4.1  
Trehalose  11.0 ± 0.2  
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Table 2. Antioxidant activity of Suillus collinitus extracts.  
 
 
Results are expressed as EC50 (concentration of extract in mg/ml that cause 50% of 
antioxidant activity or 0.5 of absorbance in the reducing power assay), and show means 
± SD of 3 independent experiments performed in triplicate. In each column, different 
letters mean significant differences between results (p<0.05).* Heleno et al., 2010. 
 
 
  
 Extracts DPPH scavenging activity β-carotene bleaching inhibition  Reducing    power 
 Methanolic* 14.1 ± 1.2a      1.2 ± 0.1a        3.0 ± 0.0a        
 
 Ethanolic  7.3 ± 0.7b        1.2 ± 0.1 a        1.3 ± 0.0c 
Boiled water  7.9 ± 0.5b        1.2 ± 0.0 a        2.1 ± 0.0b 
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Table 3. Growth inhibitory activity of Suillus collinitus extracts on human tumour cell 
lines.  
 
 
Results are expressed as GI50 (concentration of extract in µg/ml that cause 50% of cell 
growth inhibition), and show means ± SD of 3-6 independent experiments performed in 
duplicate. In each column, different letters mean significant differences between results 
(p<0.05). 
  
Extracts NCI-H460 
(lung cancer) 
MCF-7       
(breast cancer) 
HCT-15   
(colon cancer) 
AGS         
(gastric cancer) 
Methanolic 62.5 ± 6.3b 25.2 ± 0.16b 103.2 ± 9.9b 79.2 ± 15.5b 
Ethanolic 253.7 ± 2.3a 101.8 ± 8.9a 139.4± 34.1a 170.7 ± 35a 
Boiled water > 400 > 400 > 400 > 400 
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Table 4. Percentage of apoptotic MCF-7 cells induced by the methanolic extract of 
Suillus collinitus.  
 
 
 
 
Results are the mean ± SD of at least 3 independent experiments, performed in 
duplicate. In the row, different letters mean significant differences between results 
(p<0.05). 
 
 
 
  
 Blank  GI50 2× GI50
 
 
Apoptotic cells (%) 6.0 ± 0.2b  15.3 ± 2.0a 16.3 ± 2.0a  
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Figure 1. Sugars profile of Suillus collinitus obtained by HPLC-RI. 1. Arabinose; 2- 
Fructose (IS); 3- Mannitol; 4- Trehalose. 
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Figure 2. Percentage of cell growth of the methanolic (MeOH), ethanolic (EtOH) and 
boiled water extracts of Suillus collinitus against MCF-7 cells. Results are the mean ± 
SD of at least three independent experiments, performed in duplicate. 
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Figure 3. Treatment of MCF-7 cells with the methanolic extract of Suillus collinitus 
increases the % cells in G1 and decreases de % cells in the S phase of the cell cycle. 
Cell cycle analysis of MCF-7 cells treated for 48 h with the methanolic extract of 
Suillus collinitus at GI50 (25.2 µg/ml) or  twice the GI50 (50.4 µg/ml) concentrations. 
Untreated cells were used as control (blank). Results are the means ± SEM of 3-6 
independent experiments performed in duplicate. *Statistically significant different 
values when compared to blank (p<0.05).  
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Figure 4. Treatment of MCF-7 cells with the methanolic extract of Suillus collinitus 
increases p53 levels and PARP cleavage. MCF-7 cells were treated for 48 h with 
complete medium (blank) or with the extract at GI50 concentration (25.2 µg/ml) or 
2×GI50 concentration (50.4 µg/ml). Actin was used as a loading control. DMSO controls 
had no effect on the expression of the studied proteins. Results are representative of 3 
independent experiments.  
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Figure 5. Treatment of MCF-7 cells concomitantly with etoposide and Suillus collinitus 
(methanolic extract) has a greater cell growth inhibitory effect than treatment with either 
of them alone.  MCF-7 cells were treated with 1 µM of etoposide, 25.2 µg/ml of the 
methanolic extract of S. collinitus or with both together. Cell growth inhibitory activity 
was confirmed with the SRB assay. Appropriate DMSO controls had no effect on cell 
growth. Values are the mean of 4 independent experiments ± S.E.  
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